D.C. Mun. Regs. tit. 17, r. 17-6516
A pharmacist licensed in good standing in the District of Columbia shall only perform COVID-19 tests as set forth in this section.
For purposes of this section, the terms "COVID-19 test" and "COVID-19 testing" shall refer to COVID-19 diagnostic tests, COVID-19 antibody tests, and any other tests and testing mechanisms for COVID-19 that are approved by the United Stated Food and Drug Administration (FDA), or that are authorized under a FDA Emergency Use Authorization (EUA), and for which a waiver has been granted under § 2 of the Clinical Laboratory Improvement Amendments Act ( 42 U.S.C. § 263a) (CLIA).
For purposes of this section, the phrase "administer COVID-19 tests" or "administer COVID-19 testing" shall mean to administer a diagnostic COVID-19 test to a patient.
For purposes of this section, the phrase "observe and facilitate collection of self-administered COVID-19 tests" or "observe and facilitate collection of self-administered COVID-19 testing" shall mean to observe a patient self-administer a diagnostic COVID-19 test to himself or herself.
For purposes of this section, the phrase "administer COVID-19 antibody test" or "administer COVID-19 serology test" shall mean to obtain a specimen from a patient through fingerstick, nasal swab, or other CLIA-waived point of care test for purposes of testing for COVID-19 antibodies.
For purposes of this section, the phrase "processing a COVID-19 antibody test" shall mean to analyze a specimen through the use of a CLIA-waived testing mechanism to detect the presence of COVID-19 antibodies.
Only a pharmacist licensed in good standing in the District of Columbia shall administer, or supervise a licensed pharmacy intern, or registered pharmacy technician in administering, diagnostic COVID-19 testing.
The location site where diagnostic COVID-19 testing is administered shall meet the requirements set forth in § 6516.9 or § 6516.10 of this chapter.
A COVID-19 testing location operated by a pharmacy in a non-institutional pharmacy setting that performs diagnostic COVID-19 testing shall:
A COVID-19 testing location operated by a pharmacy in an off-site location that performs diagnostic COVID-19 testing shall by approved by the Director, subject to inspection by the Department, and comply with all relevant Center for Disease Control and Prevention ("CDC") requirements and guidelines for the operation of testing locations available on the CDC website (www.cdc.gov), as they may be from time to time amended.
All pharmacists, pharmacy interns, and pharmacy technicians involved in administering diagnostic COVID-19 testing shall comply with current CDC requirements and guidelines for personnel collecting specimens or working within six (6) feet of patients available on the CDC website (www.cdc.gov), as they may be from time to amended.
The pharmacist-in-charge of a pharmacy where diagnostic COVID-19 testing will be administered, shall:
Only a pharmacist licensed in good standing in the District of Columbia shall observe and facilitate collection of self-administered COVID-19 testing or supervise a licensed pharmacy intern or registered pharmacy technician in observing and facilitating collection of self-administered COVID-19 testing.
The location site where authorized pharmacy personnel observe and facilitate collection of self-administered COVID-19 testing occurs shall meet the requirements set forth in § 6516.10 or § 6516.15 of this chapter.
Except as provided in § 6516.10 or § 6516.16, a COVID-19 testing location operated by a pharmacy in a non-institutional pharmacy setting where authorized pharmacy personnel observe and facilitate collection of self-administered COVID-19 testing shall:
A COVID-19 testing location operated by a pharmacy in a non-institutional setting where authorized pharmacy personnel observe and facilitate collection of self-administered COVID-19 testing may perform the observation through a drive through window only if the pharmacy complies with the requirements set forth below:
All pharmacists, pharmacy interns, and pharmacy technicians who observe and facilitate collection of self-administered COVID-19 testing shall comply with current CDC requirements and guidelines for PPE for personnel who are handling specimens but not directly involved in collection and who are not working within six (6) feet of the patient available on the CDC website (www.cdc.gov), as they may be from time to time amended.
The pharmacist-in-charge of a pharmacy where authorized pharmacy personnel observe and facilitate collection of self-administered COVID-19 testing, shall implement appropriate policies and procedures for the safe performance of COVID-19 testing at that location, which shall include ensuring compliance with current CDC requirements and guidelines for appropriate training, collection procedures, availability and use of PPE, proper disposal of used PPE, and appropriate staffing levels available on the CDC website (www.cdc.gov), as they may be from time to time amended.
Only a pharmacist licensed in good standing in the District of Columbia shall administer or supervise a licensed pharmacy intern, or registered pharmacy technician to administer a COVID-19 antibody or serology test.
The location site where COVID-19 antibody or serology testing is administered which requires removal of a patient's mask, or in which the patient's sputum or other bodily fluids may potentially become aerosolized, shall meet the requirements set for in § 6516.9 or § 6516.10 of this chapter.
The location site where COVID-19 antibody or serology testing occurs using fingerstick or other point of care testing in which there is no potential for the patient's bodily fluids to become aerosolized, shall meet the requirements set forth in § 6516.22 of this chapter.
A COVID-19 testing location operated by a pharmacy in a non-institutional setting where authorized pharmacy personnel administer COVID-19 antibody or serology testing in which there is no potential for the patient's bodily fluids to become aerosolized shall:
All pharmacists, pharmacy interns, and pharmacy technicians who administer COVID-19 antibody or serology testing shall comply with current CDC requirements and guidelines for PPE for personnel who are handling specimens but not directly involved in collection and who are not working within six (6) feet of the patient available on the CDC website (www.cdc.gov), as they may be from time to time amended.
The pharmacist-in-charge of a pharmacy where authorized pharmacy personnel administer COVID-19 antibody or serology testing, shall implement appropriate policies and procedures for the safe performance of COVID-19 testing at that location, which shall include ensuring compliance with current CDC requirements and guidelines for appropriate training, collection procedures, availability and use of PPE, proper disposal of used PPE, and appropriate staffing levels available on the CDC website (www.cdc.gov) as they may be from time to time amended.
Prior to performing COVID-19 testing, a pharmacist shall review and familiarize himself/herself with the Center for Disease Control's "Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 (COVID-19)" available on the CDC website (www.cdc.gov) as they may be from time to time amended, and ensure that the pharmacist and authorized pharmacypersonnel have appropriate PPE to safely perform the testing.
The health care practitioner who orders the COVID-19 test, who may be the same pharmacist who administers the test, shall be responsible for receiving the test results and directing a patient with a positive test result to receive care and monitoring.
D.C. Mun. Regs. tit. 17, r. 17-6516